BackReviva Pharmaceuticals Holdings Overview

Reviva Pharmaceuticals Holdings Net Income

Profitability analysis for RVPH.

Quarterly Net Income

-$3.20M
50.32% YoY

As of Mar 2026

Annual Net Income (TTM)

-$19864.90B
68693707.43% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...